Pharming Appoints Karl Keegan as CFO

Biotech company Pharming Group has appointed Dr Karl Keegan as chief financial officer (CFO). Keegan will be responsible for all financial and financing activities, corporate communications and investor relations. In addition, he will work together with Dr Sijmen de Vries, chief executive officer (CEO), in furthering the company’s business development activities.


Related reading